Abstract

Proteostasis is critical for cells to maintain the balance between protein synthesis, quality control, and degradation. This is particularly important for myeloid cells of the central nervous system as their immunological function relies on proper intracellular protein turnover by the ubiquitin-proteasome system. Accordingly, disruption of proteasome activity due to, e.g., loss-of-function mutations within genes encoding proteasome subunits, results in systemic autoinflammation. On the molecular level, pharmacological inhibition of proteasome results in endoplasmic reticulum (ER) stress-activated unfolded protein response (UPR) as well as an induction of type I interferons (IFN). Nevertheless, our understanding as to whether and to which extent UPR signaling regulates type I IFN response is limited. To address this issue, we have tested the effects of proteasome dysfunction upon treatment with proteasome inhibitors in primary murine microglia and microglia-like cell line BV-2. Our data show that proteasome impairment by bortezomib is a stimulus that activates all three intracellular ER-stress transducers activation transcription factor 6, protein kinase R-like endoplasmic reticulum kinase and inositol-requiring protein 1 alpha (IRE1α), causing a full activation of the UPR. We further demonstrate that impaired proteasome activity in microglia cells triggers an induction of IFNβ1 in an IRE1-dependent manner. An inhibition of the IRE1 endoribonuclease activity significantly attenuates TANK-binding kinase 1-mediated activation of type I IFN. Moreover, interfering with TANK-binding kinase 1 activity also compromised the expression of C/EBP homologous protein 10, thereby emphasizing a multilayered interplay between UPR and type IFN response pathway. Interestingly, the induced protein kinase R-like endoplasmic reticulum kinase-activation transcription factor 4-C/EBP homologous protein 10 and IRE1-X-box-binding protein 1 axes caused a significant upregulation of proinflammatory cytokine interleukin 6 expression that exacerbates STAT1/STAT3 signaling in cells with dysfunctional proteasomes. Altogether, these findings indicate that proteasome impairment disrupts ER homeostasis and triggers a complex interchange between ER-stress sensors and type I IFN signaling, thus inducing in myeloid cells a state of chronic inflammation.

Highlights

  • Proteostasis is a protein homeostasis process ensuring an intracellular balance between generation of newly synthesized proteins and degradation

  • Our results support a role for the unfolded protein response (UPR) in triggering neuroinflammation, which is a key component of neurodegenerative diseases

  • As part of pathogenesis of proteasome-related interferonopathies (CANDLE/PRAAS), the induction of type I IFN and proinflammatory cytokines has been long associated with activity of the UPR [34, 36]

Read more

Summary

Introduction

Proteostasis is a protein homeostasis process ensuring an intracellular balance between generation of newly synthesized proteins and degradation. Degradation of misfolded proteins, oxidant-damaged proteins, and short-lived regulatory proteins requires the activity of the ubiquitin-proteasome system (UPS) [1,2,3]. Polyubiquitylated proteins are subsequently degraded by the 26S proteasome, which consists of the 20S catalytic core complex and the 19S regulatory complexes. The adequate adaptation of the UPS to the increased demand for protein degradation by engaging the DDI2/NRF1 axis [10, 11], activation of the ER-stress pathways [12], and/or induction of immunoproteasomes [9, 13] is of fundamental importance for cells and tissues, which are otherwise faced with the risk of an accumulation of damaged or misfolded proteins, and/ or induction of cell death

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call